Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

May 31, 2023

Study Completion Date

January 15, 2024

Conditions
Carcinoma, Non- Small Cell Lung
Interventions
DRUG

Durvalumab

Intravenous administration of Durvalumab

OTHER

Placebo

Placebo Comparator

Trial Locations (115)

235

Research Site, Taipei

333

Research Site, Taoyuan District

613

Research Site, Chiayi City

1083

Research Site, Budapest

1121

Research Site, Budapest

2045

Research Site, Törökbálint

2050

Research Site, Camperdown

2065

Research Site, St Leonards

3000

Research Site, Melbourne

3200

Research Site, Gyöngyös - Mátraháza

3500

Research Site, Hasselt

5004

Research Site, Szolnok

8000

Research Site, Székesfehérvár

8800

Research Site, Roeselare

9024

Research Site, Győr

10043

Research Site, Orbassano

11029

Research Site, New Delhi

11217

Research Site, Taipei

11526

Research Site, Athens

11527

Research Site, Athens

13915

Research Site, Marseille

15706

Research Site, Santiago de Compostela

16247

Research Site, Suwon

20052

Research Site, Monza

20089

Research Site, Rozzano

20133

Research Site, Milan

28041

Research Site, Madrid

28644

Research Site, Cheongju-si

29010

Research Site, Málaga

29303

Research Site, Spartanburg

31008

Research Site, Pamplona

31096

Research Site, Haifa

32117

Research Site, Daytona Beach

32605

Research Site, Gainesville

33011

Research Site, Oviedo

33604

Research Site, Pessac

33980

Research Site, Punta Gorda

34010

Research Site, Istanbul

34214

Research Site, Istanbul

37203

Research Site, Nashville

40201

Research Site, Taichung

40241

Research Site, Louisville

41110

Research Site, Larissa

44280

Research Site, Malatya

44805

Research Site, Saint-Herblain

47014

Research Site, Meldola

49100

Research Site, Petah Tikva

52621

Research Site, Ramat Gan

54645

Research Site, Thessaloniki

55404

Research Site, Minneapolis

67091

Research Site, Strasbourg

70000

Research Site, Ho Chi Minh City

Research Site, Hochiminh

70403

Research Site, Tainan City

71110

Research Site, Heraklion

77900

Research Site, Olomouc

84112

Research Site, Salt Lake City

90089

Research Site, Los Angeles

90806

Research Site, Long Beach

91120

Research Site, Jerusalem

100000

Research Site, Hanoi

105229

Research Site, Moscow

115478

Research Site, Moscow

119228

Research Site, Singapore

169610

Research Site, Singapore

191036

Research Site, Saint Petersburg

197758

Research Site, Saint Petersburg

308433

Research Site, Singapore

560099

Research Site, Bengaluru

630108

Research Site, Novosibirsk

4428164

Research Site, Kfar Saba

C1125ABD

Research Site, Buenos Aires

14784-400

Research Site, Barretos

88034-000

Research Site, Florianópolis

90610-000

Research Site, Porto Alegre

15090-000

Research Site, São José do Rio Preto

29043-260

Research Site, Vitória

V8R 6V5

Research Site, Victoria

E2L 4L2

Research Site, Saint John

K7L 2V7

Research Site, Kingston

K1H 8L6

Research Site, Ottawa

H4A 3J1

Research Site, Montreal

703 00

Research Site, Ostrava

128 08

Research Site, Prague

155 62

Research Site, Holargos, Athens

Unknown

Research Site, Hong Kong

Research Site, Jordan

Research Site, Kaohsiung City

00144

Research Site, Roma

160-0023

Research Site, Bunkyō City

734-8551

Research Site, Hiroshima

277-8577

Research Site, Kashiwa

135-8550

Research Site, Kōtoku

534-0021

Research Site, Osaka

541-8567

Research Site, Osaka

591-8555

Research Site, Sakaishi

980-0873

Research Site, Sendai

411-8777

Research Site, Sunto-gun

241-8515

Research Site, Yokohama

4818 CK

Research Site, Breda

6202 AZ

Research Site, Maastricht

8025 AB

Research Site, Zwolle

Lima 32

Research Site, Lima

LIMA 34

Research Site, Lima

85-796

Research Site, Bydgoszcz

80-214

Research Site, Gdansk

97-200

Research Site, Tomaszów Mazowiecki

02-781

Research Site, Warsaw

05505

Research Site, Seoul

06351

Research Site, Seoul

06591

Research Site, Seoul

08035

Research Site, Barcelona

08041

Research Site, Barcelona

01120

Research Site, Adana

06010

Research Site, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY